Novo Holdings Pharvaris N.V. Transaction History
Novo Holdings
- $1.23 Billion
- Q4 2024
A detailed history of Novo Holdings transactions in Pharvaris N.V. stock. As of the latest transaction made, Novo Holdings holds 1,725,000 shares of PHVS stock, worth $28.8 Million. This represents 2.69% of its overall portfolio holdings.
Number of Shares
1,725,000
Previous 1,725,000
-0.0%
Holding current value
$28.8 Million
Previous $31.9 Million
3.51%
% of portfolio
2.69%
Previous 2.23%
Shares
11 transactions
Others Institutions Holding PHVS
# of Institutions
53Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$126 Million5.17% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$73.3 Million77.49% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$71.5 Million67.66% of portfolio
-
Viking Global Investors LP3.65MShares$60.9 Million0.24% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$55.1 Million17.1% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $563M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...